145 related articles for article (PubMed ID: 30623045)
1. Implementation of the Ogata flow cytometric scoring system in routine diagnostics of myelodysplastic syndrome.
Matzen SMH; Raaschou-Jensen KK; Kallenbach K
Health Sci Rep; 2018 Nov; 1(11):e90. PubMed ID: 30623045
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
[TBL] [Abstract][Full Text] [Related]
3. A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
Kárai B; Bedekovics J; Miltényi Z; Gergely L; Szerafin L; Ujfalusi A; Kappelmayer J; Hevessy Z
Int J Lab Hematol; 2017 Dec; 39(6):577-584. PubMed ID: 28625017
[TBL] [Abstract][Full Text] [Related]
4. [Abnormality of immunophenotyping in patients with myelodysplastic syndrome].
Xu J; Guo YX; Zhao H; Hui WH; Wan SG; Sun XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):894-7. PubMed ID: 19698224
[TBL] [Abstract][Full Text] [Related]
5. [Value of multiparameter flow cytometry in the diagnosis and prognostic evaluation of childhood myelodysplastic syndrome].
Liu C; An WB; Zhang JL; Zhang RR; Sun CC; Chang LX; Liu TF; Zou Y; Wang HJ; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Oct; 20(10):819-824. PubMed ID: 30369356
[TBL] [Abstract][Full Text] [Related]
6. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.
Wells DA; Benesch M; Loken MR; Vallejo C; Myerson D; Leisenring WM; Deeg HJ
Blood; 2003 Jul; 102(1):394-403. PubMed ID: 12649150
[TBL] [Abstract][Full Text] [Related]
7. A Novel Multicolor Flow Cytometry Scoring System for the Diagnosis and Prognostic Stratification of Myelodysplastic Syndromes.
Lai B; Chen Y; Li M; Ye G; Luo H; Zhong Y; Guo X
Clin Lab; 2022 Sep; 68(9):. PubMed ID: 36125138
[TBL] [Abstract][Full Text] [Related]
8. Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome.
Scott BL; Wells DA; Loken MR; Myerson D; Leisenring WM; Deeg HJ
Blood; 2008 Oct; 112(7):2681-6. PubMed ID: 18606877
[TBL] [Abstract][Full Text] [Related]
9. Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Bardet V; Wagner-Ballon O; Guy J; Morvan C; Debord C; Trimoreau F; Benayoun E; Chapuis N; Freynet N; Rossi C; Mathis S; Gourin MP; Toma A; Béné MC; Feuillard J; Guérin E; ;
Haematologica; 2015 Apr; 100(4):472-8. PubMed ID: 25637056
[TBL] [Abstract][Full Text] [Related]
10. Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.
Alhan C; Westers TM; van der Helm LH; Eeltink C; Huls G; Witte BI; Buchi F; Santini V; Ossenkoppele GJ; van de Loosdrecht AA
Cytometry B Clin Cytom; 2014 May; 86(3):207-15. PubMed ID: 24474614
[TBL] [Abstract][Full Text] [Related]
11. Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.
Alhan C; Westers TM; van der Helm LH; Eeltink C; Huls G; Witte BI; Buchi F; Santini V; Ossenkoppele GJ; van de Loosdrecht AA
Cytometry B Clin Cytom; 2014 Jan; ():. PubMed ID: 24431028
[TBL] [Abstract][Full Text] [Related]
12. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes.
Alhan C; Westers TM; Cremers EM; Cali C; Witte BI; Ossenkoppele GJ; van de Loosdrecht AA
Br J Haematol; 2014 Oct; 167(1):100-9. PubMed ID: 24976502
[TBL] [Abstract][Full Text] [Related]
13. Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact.
Oelschlaegel U; Oelschlaeger L; von Bonin M; Kramer M; Sockel K; Mohr B; Wagenfuehr L; Kroschinsky F; Bornhaeuser M; Platzbecker U
Cytometry B Clin Cytom; 2023 Mar; 104(2):141-150. PubMed ID: 34390327
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of multiparametric flow cytometry in diagnosis & prognosis of myelodysplastic syndrome in India.
Dhingra G; Dass J; Arya V; Gupta N; Saraf A; Langer S; Aggarwal S; Kotwal J; Bhargava M
Indian J Med Res; 2020 Sep; 152(3):254-262. PubMed ID: 33107485
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.
Aanei CM; Picot T; Tavernier E; Guyotat D; Campos Catafal L
Front Oncol; 2016; 6():161. PubMed ID: 27446807
[TBL] [Abstract][Full Text] [Related]
16. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
[TBL] [Abstract][Full Text] [Related]
17. The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study.
Chauhan R; Singh J; Sharma C; Dange P; Chopra A; Mahapatra M; Pati H
Leuk Res; 2021 Aug; 107():106651. PubMed ID: 34218155
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia.
Muyldermans A; Florin L; Devos H; Cauwelier B; Emmerechts J
Hematology; 2019 Dec; 24(1):166-172. PubMed ID: 30334700
[TBL] [Abstract][Full Text] [Related]
19. Comparison of flow cytometry with other modalities in the diagnosis of myelodysplastic syndrome.
Pembroke JS; Joseph JE; Smith SABC; Parker AJC; Jiang W; Sewell WA
Int J Lab Hematol; 2022 Apr; 44(2):313-319. PubMed ID: 34841680
[TBL] [Abstract][Full Text] [Related]
20. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
Lu D; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]